Environmental Science & Technology · 2021 · 92 citations · 36 references
PharmacyChemistryToxicologyAnalytical ChemistryAnalytical ToxicologyMass Spectrometric AnalysisContaminant AnalysisInstrumental AnalysisMass SpectrometryPerinatal ToxicologyPrenatal ToxicologyRisk Assessment For Developmental ToxicantsFragmentationFragmentation Pattern AnalysisLiquid Chromatography-mass SpectrometryMass Spectrometric ScreeningNegative IonizationSuspect Sample ScreeningTandem Mass Spectrometry AnalysisTandem Mass Spectrometry Screening
= 60). We matched 662 suspect features in positive ionization mode and 788 in negative ionization mode (557 unique formulas overall) to compounds in our database, and selected 208 of these for fragmentation analysis based on detection frequency, correlation in feature intensity between maternal and cord samples, and peak area differences by demographic characteristics. We tentatively identified 73 suspects through fragmentation spectra matching and confirmed 17 chemical features (15 unique compounds) using analytical standards. We tentatively identified 55 compounds not previously reported in the literature, the majority which have limited to no information about their sources or uses. Examples include (i) 1-(1-acetyl-2,2,6,6-tetramethylpiperidin-4-yl)-3-dodecylpyrrolidine-2,5-dione (known high production volume chemical) (ii) methyl perfluoroundecanoate and 2-perfluorooctyl ethanoic acid (two PFAS compounds); and (iii) Sumilizer GA 80 (plasticizer). Thus, our workflow demonstrates an approach to evaluating the chemical exposome to identify and prioritize chemical exposures during a critical period of development.
36
HMDB 4.0: the human metabolome database for 2018
David S. Wishart, Yannick Djoumbou-Feunang, Ana Marcu et al. · Nucleic Acids Research · 2017 · 3.6K citations · Full text